Yasuto Itoyama

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 900 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Neurological Disorder +6

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis

Tatsuro Misu, Kazuo Fujihara, Akiyoshi Kakita et al. · Brain · 2007 · 607 citations · Full text

Interleukin-1 as a Pathogenetic Mediator of Ischemic Brain Damage in Rats

Yasundo Yamasaki, Naosuke Matsuura, Hidetaka Shozuhara et al. · Stroke · 1995 · 571 citations

Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo

Monika Bradl, Tatsuro Misu, Toshiyuki Takahashi et al. · Annals of Neurology · 2009 · 549 citations

Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response

Taiichi Katayama, Kazunori Imaizumi, Naoya Sato et al. · Nature Cell Biology · 1999 · 518 citations

Signal Transduction, Signaling Pathway, Protein Folding +11